We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
-14.86%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$134B
AUM Growth
-$30.1B
Cap. Flow
-$1.57B
Cap. Flow %
-1.17%
Top 10 Hldgs %
29.15%
Holding
6,955
New
507
Increased
2,096
Reduced
2,889
Closed
579

Sector Composition

Rank Sector Weight
1 Technology 10.07%
2 Financials 5.69%
3 Healthcare 5.49%
4 Consumer Discretionary 4.41%
5 Industrials 3.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INFI
5651
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$3K ﹤0.01%
4,221
-931
-18% -$715
SPPI
5652
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$3K ﹤0.01%
4,160
-10,617
-72% -$9.36K
ONCR
5653
DELISTED
Oncorus, Inc.
ONCR
$3K ﹤0.01%
2,126
+692
+48% +$940
WEJO
5654
DELISTED
Wejo Group Limited Common Shares
WEJO
$3K ﹤0.01%
2,565
+1,965
+328% +$4.59K
TCRR
5655
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$3K ﹤0.01%
1,035
-1,107
-52% -$2.73K
IQMDW
5656
CALL
DELISTED
Intelligent Medicine Acquisition Corp. Warrant
IQMDW
$3K ﹤0.01%
25,001
CDAK
5657
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$3K ﹤0.01%
1,143
-27
-2% -$95
OBSV
5658
DELISTED
ObsEva SA Ordinary Shares
OBSV
$3K ﹤0.01%
1,650
-1,565
-49% -$2.58K
CYRN
5659
DELISTED
CYREN Ltd.
CYRN
$3K ﹤0.01%
1,326
-190
-13% -$431
DCRDW
5660
CALL
DELISTED
Decarbonization Plus Acquisition Corporation IV Warrant
DCRDW
$3K ﹤0.01%
12,551
APN.WS
5661
CALL
DELISTED
Apeiron Capital Investment Corp. Redeemable Warrants
APN.WS
$3K ﹤0.01%
37,501
RBCN
5662
DELISTED
Rubicon Technology, Inc.
RBCN
$3K ﹤0.01%
+363
New +$3.32K
POND.WS
5663
CALL
DELISTED
Angel Pond Holdings Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
POND.WS
$3K ﹤0.01%
6,967
TMAC.WS
5664
CALL
DELISTED
The Music Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
TMAC.WS
$3K ﹤0.01%
35,046
WARR.WS
5665
CALL
DELISTED
Warrior Technologies Acquisition Company Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
WARR.WS
$3K ﹤0.01%
50,000
LUNA
5666
DELISTED
Luna Innovations Incorporated
LUNA
$3K ﹤0.01%
556
-573
-51% -$3.38K
INTEW
5667
CALL
DELISTED
Integral Acquisition Corporation 1 Warrants
INTEW
$3K ﹤0.01%
23,401
ADTX
5668
DELISTED
ADITXT INC
ADTX
0
AKA icon
5669
a.k.a. Brands
AKA
$119M
$2K ﹤0.01%
66
+35
+113% +$1.54K
ALGS icon
5670
Aligos Therapeutics
ALGS
$26.3M
$2K ﹤0.01%
64
-214
-77% -$7.27K
ALZN icon
5671
Alzamend Neuro
ALZN
$6.28M
$2K ﹤0.01%
+1
New +$1.3K
APT icon
5672
Alpha Pro Tech
APT
$51.1M
$2K ﹤0.01%
+500
New +$2.13K
APYX icon
5673
Apyx Medical
APYX
$163M
$2K ﹤0.01%
311
-1,309
-81% -$6.72K
ASTS icon
5674
AST SpaceMobile
ASTS
$16.9B
$2K ﹤0.01%
300
-107
-26% -$839
AVDL
5675
DELISTED
Avadel Pharmaceuticals
AVDL
$2K ﹤0.01%
859
-368
-30% -$1.51K

Similar funds

Citigroup's Q2 2022 Portfolio in Review

As of Q2 2022, Citigroup held 6,955 positions worth $134B, down 18% from $165B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Citigroup's Q2 2022 filing shows 507 new, 2,096 increased, 2,889 reduced and 579 closed positions. Its largest new stake was State Street SPDR MarketAxess Investment Grade 400 Corporate Bond ETF: 250,000 shares worth $24.7M. The largest sale was iShares Russell 2000 ETF, an estimated $565M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.

  • Citigroup's largest Q2 2022 buy was State Street SPDR MarketAxess Investment Grade 400 Corporate Bond ETF: 250,000 shares worth $24.7M.
  • Citigroup added most to Invesco QQQ Trust in Q2 2022, an estimated $628M increase.
  • Citigroup's biggest Q2 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $565M.
  • Citigroup fully exited People's United Financial Inc in Q2 2022, selling an estimated $103M.
  • Citigroup's ten largest holdings make up 29% of its $134B portfolio in Q2 2022.
  • Citigroup opened 507 new positions and closed 579 in Q2 2022.
  • Citigroup's portfolio value fell 18% quarter-over-quarter to $134B.

Based on Citigroup's 13F filing for Q2 2022, filed 10 Aug 2022.